ES2061850T3 - Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna. - Google Patents
Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.Info
- Publication number
- ES2061850T3 ES2061850T3 ES89116679T ES89116679T ES2061850T3 ES 2061850 T3 ES2061850 T3 ES 2061850T3 ES 89116679 T ES89116679 T ES 89116679T ES 89116679 T ES89116679 T ES 89116679T ES 2061850 T3 ES2061850 T3 ES 2061850T3
- Authority
- ES
- Spain
- Prior art keywords
- marek
- disease
- fragment
- virus
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Abstract
SE DESCRIBE UNA MODIFICACION DEL MAL DE MAREK, LA CUAL COMPRENDE LA ESTRUCTURA COMPLETA DEL VIRUS DEL MAL DE MAREK Y UN FRAGMENTO DE DNA INCORPORADO A ELLA, CONTENIENDO DICHO FRAGMENTO DE DNA UN PORTADOR DERIVADO DE UNA CELULA ANIMAL O DE UN VIRUS ANIMAL Y UNA ESTRUCTURA DE GENE CODIFICADA PARA UNA PROTEINA EXOGENA. ADICIONALMENTE SE DESCRIBE UN PROCESO PARA PREPARAR DICHO VIRUS MODIFICADO, EL CUAL COMPRENDE PREPARAR UN FRAGMENTO DE GENE EN DONDE UNA CODIFICACION DE ESTRUCTURA GENETICA PARA UN GEN EXOGENO SE LOCALIZA CADENA ABAJO DE UN PORTADOR DERIVADO DE UNA CELULA ANIMAL O DE UN VIRUS ANIMAL, INCORPORANDO DICHO FRAGMENTO DE GEN EL FRAGMENTO BAMHL-H DE UN GEN DEL VIRUS DE LA ENFERMEDAD DE MAREK DE TIPO I, E INCORPORANDO DICHO FRAGMENTO UN VIRUS DE LA ENFERMEDAD DE MAREK TIPO I COMPLETO. FINALMENTE SE DESCRIBE UNA VACUNA ACTIVA POLIVALENTE PARA PAJAROS, LA CUAL CONTIENE EL VIRUS ANTERIOR MODIFICADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63226960A JP2583115B2 (ja) | 1988-09-10 | 1988-09-10 | 組換えマレック病ウイルスおよびその製法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061850T3 true ES2061850T3 (es) | 1994-12-16 |
Family
ID=16853319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89116679T Expired - Lifetime ES2061850T3 (es) | 1988-09-10 | 1989-09-08 | Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5171677A (es) |
EP (1) | EP0361182B1 (es) |
JP (1) | JP2583115B2 (es) |
AT (1) | ATE100495T1 (es) |
CA (1) | CA1339774C (es) |
DE (1) | DE68912478T2 (es) |
ES (1) | ES2061850T3 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634636A (en) * | 1983-12-13 | 1987-01-06 | Asahi Kasei Kogyo Kabushiki Kaisha | Polyacetylene composite |
US5928648A (en) * | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5961982A (en) * | 1985-09-06 | 1999-10-05 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
NL9001828A (nl) * | 1990-08-15 | 1992-03-02 | Centraal Diergeneeskundig Inst | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
US5853733A (en) * | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
WO1995018860A1 (en) * | 1994-01-11 | 1995-07-13 | Cornell Research Foundation, Inc. | Control of marek's disease by the inhibition of latency and tumor cell development |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
JPH08322559A (ja) * | 1995-06-02 | 1996-12-10 | Chemo Sero Therapeut Res Inst | gB遺伝子プロモーターを用いた組換えヘルペスウイルス |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US128836A (en) * | 1872-07-09 | Improvement in draught-regulators | ||
JP2559384B2 (ja) * | 1985-07-29 | 1996-12-04 | ジ・アップジョン・カンパニ− | ウイルスワクチン |
AU623333B2 (en) * | 1986-01-27 | 1992-05-14 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
JPH02502693A (ja) * | 1987-03-19 | 1990-08-30 | サイナーゲン,インコーポレーテッド | 外来dna発現産物の家禽類への導入のためのウイルスベクター系およびその作製方法 |
AU628294B2 (en) * | 1987-07-27 | 1992-09-17 | Syntro Corporation | Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
JP2779447B2 (ja) * | 1988-03-20 | 1998-07-23 | 財団法人阪大微生物病研究会 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
-
1988
- 1988-09-10 JP JP63226960A patent/JP2583115B2/ja not_active Expired - Fee Related
-
1989
- 1989-09-08 US US07/404,500 patent/US5171677A/en not_active Expired - Lifetime
- 1989-09-08 AT AT89116679T patent/ATE100495T1/de not_active IP Right Cessation
- 1989-09-08 EP EP89116679A patent/EP0361182B1/en not_active Expired - Lifetime
- 1989-09-08 DE DE89116679T patent/DE68912478T2/de not_active Expired - Lifetime
- 1989-09-08 ES ES89116679T patent/ES2061850T3/es not_active Expired - Lifetime
- 1989-09-08 CA CA000610801A patent/CA1339774C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0276578A (ja) | 1990-03-15 |
CA1339774C (en) | 1998-03-24 |
DE68912478D1 (de) | 1994-03-03 |
EP0361182A1 (en) | 1990-04-04 |
EP0361182B1 (en) | 1994-01-19 |
JP2583115B2 (ja) | 1997-02-19 |
DE68912478T2 (de) | 1994-05-11 |
US5171677A (en) | 1992-12-15 |
ATE100495T1 (de) | 1994-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910012233A (ko) | 칠면조의 재조합 포진바이러스와 그것에서 유도한 생존상태의 벡터 백신류 | |
DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
Cleveland et al. | Conservation of microtubule associated proteins. Isolation and characterization of tau and the high molecular weight microtubule associated protein from chicken brain and from mouse fibroblasts and comparison to the corresponding mammalian brain proteins | |
DE69505493T2 (de) | Wirt-vektor system zur anwendung in gentherapie | |
AU3069889A (en) | Pox virus vectors | |
PT90687A (pt) | Baculovirus modificado, processo para a sua preparacao e sua aplicacao como vector de expressao de genes | |
ES2061850T3 (es) | Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna. | |
DE69131903D1 (de) | Klonierung hühner-anaemia-virus-dna | |
LU91303I2 (fr) | Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP | |
SG55095A1 (en) | Viruses and their use as a vaccine against feline infectious peritonitis virus disease | |
KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
RU2002100209A (ru) | Gm-csf лошади | |
DE69233004D1 (de) | Rekombinanter Virus der Marek-Krankheit, Verfahren zur Herstellung dieses Viruses und diesen enthaltender Impfstoff | |
FR2600079B1 (fr) | Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus | |
KR930701588A (ko) | 재조합 구두 바이러스 백신 | |
CA2196416A1 (en) | Recombinant herpes virus with gb gene promoter | |
RU98116217A (ru) | Способ получения белка с использованием трансляционной системы митохондрий | |
BR9801992A (pt) | Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero. | |
Morgan et al. | Recombinant vaccine against Marek's disease | |
TH4993A (th) | การถอดรหัสของเฮพาไททีสบีแอนติเจนจากพาหะรีคอมบิแนนท์บาคิวโลไวรัส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 361182 Country of ref document: ES |